Connor, Clark & Lunn Investment Management (CC&L)’s Dyne Therapeutics DYN Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-41,157	Closed	-$1.48M	–	1456
2024 Q3	$1.48M	Buy	+41,157	New	+$1.48M	0.01%	751
2023 Q2	–	Sell	-21,010	Closed	-$242K	–	1365
2023 Q1	$242K	Buy	+21,010	New	+$242K	﹤0.01%	1056